GammaCan International Inc.
GammaCan announces positive pre-IND meeting on VitiGam for metastatic malignant melanoma
Published in Food and Drug Law Weekly, April 21st, 2006
GammaCan's scientists, led by professor Yehuda Shoenfeld, MD, have previously shown that plasma-derived IVIg has anti-cancer activity in a number of animal models. More recently, GammaCan has initiated an open label Phase II trial evaluating the anti-cancer properties of plasma-derived IVIg. This trial is expected to conclude later this year and data will be presented after it...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Aastrom Biosciences, Inc.
Aastrom Biosciences gets orphan drug designation for bone marrow cells - Arbios Systems, Inc.
Arbios receives U.S. FDA allowance to increase patient enrollment for Sepet trial - Attention Deficit Hyperactivity Disorder
Data show adults continue to outpace children in ADHD medication use - Avicena Group, Inc.
Avicena compound receives orphan drug designation for Huntington disease - BioLok International, Inc.
BioLok International receives U.S. FDA clearance for bone augmentation product - Biogen Idec
FDA extends review period for reintroduction of Tysabri for multiple sclerosis - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
